Floatz logo

35 assets in Peritoneum Cancer

Therapeutic assets addressing Peritoneum Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cyclophosphamide
Peritoneum Cancer
Peking UniversityP2BB (71)
Fluorouracilum
Peritoneum Cancer
City of Hope Medical CenterP3BB (69)
Mirvetuximab Soravtansine
Peritoneum Cancer
AbbVieP3BB (68)
Carboplatin
Peritoneum Cancer
Qilu Hospital of Shandong UniversityP3BB (66)
Irinotecan
Peritoneum Cancer
City of Hope Medical CenterP3BB (66)
Rucaparib
Peritoneum Cancer
pharmaand GmbHP3BB (66)
Adriamycin
Peritoneum Cancer
Brigham and Women's HospitalP3BB (65)
Muamycin
Peritoneum Cancer
City of Hope Medical CenterP3B (63)
Cis-Diamminedichloroplatinum Ii
Peritoneum Cancer
Unidade Local de Saúde São JoãoP2B (62)
Niraparib
Peritoneum Cancer
AGO Study GroupP3B (62)
Nivolumab
Peritoneum Cancer
Enlivex Therapeutics RDO Ltd.P2B (60)
Oregovamab
Peritoneum Cancer
CanariaBio Inc.P3CCC (54)
Bet Bromodomain Inhibitor Zen-3694
Peritoneum Cancer
Alexander B Olawaiye, MDP2CCC (53)
Fluzoparib
Peritoneum Cancer
Qilu Hospital of Shandong UniversityP2CCC (53)
Lubiprostone
Peritoneum Cancer
Sun Yat-sen UniversityP2CCC (53)
Mirvetuximab Soravtansine-Gynx
Peritoneum Cancer
University of Colorado, DenverP2CCC (53)
Olaparib
Peritoneum Cancer
University of Colorado, DenverP2CCC (53)
Omburtamab
Peritoneum Cancer
Memorial Sloan Kettering Cancer CenterP2CCC (53)
sg001
Peritoneum Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.P2CCC (53)
Talazoparib
Peritoneum Cancer
Alexander B Olawaiye, MDP2CCC (53)
Fludarabine
Peritoneum Cancer
Peking UniversityP1/2CCC (52)
Fractalkine Receptor Antagonist Kand567
Peritoneum Cancer
Novakand Pharma ABP1/2CCC (48)
Oxaliplatin
Peritoneum Cancer
Arjun MittraP1CC (46)
Allocetra-Ots
Peritoneum Cancer
Enlivex Therapeutics RDO Ltd.P1/2CC (45)
Pasifolate Exatecan
Peritoneum Cancer
Elucida OncologyP1/2CC (45)
Tislelizumab
Peritoneum Cancer
Enlivex Therapeutics RDO Ltd.P1/2CC (45)
Acm-Cpg
Peritoneum Cancer
Brown UniversityP1CC (43)
Azenosertib
Peritoneum Cancer
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, IncP1CC (41)
Bl-M17D1
Peritoneum Cancer
SystImmune Inc.P1CC (41)
bp1001-a
Peritoneum Cancer
Bio-Path Holdings, Inc.P1CC (41)
Enoblituzumab
Peritoneum Cancer
Masonic Cancer Center, University of MinnesotaP1CC (41)
b7h3 car-γδt cells
Peritoneum Cancer
Peking UniversityEarly P1C (39)
Aspirin
Peritoneum Cancer
H. Lee Moffitt Cancer Center and Research InstituteEarly P1C (38)
Huaier Granule
Peritoneum Cancer
Ruijin HospitalN/AD (30)
ft538
Peritoneum Cancer
Masonic Cancer Center, University of MinnesotaP1D (27)